The Society for Maternal-Fetal Medicine (SMFM) 43rd Annual Pregnancy Meeting

Intermittent outdoes continuous catheterization for postpartum urinary retention

Audrey Abella, 20230227100000

In women with postpartum urinary retention (PUR; bladder volume ≥150 mL) up to 6 hours following vaginal or Caesarean delivery, intermittent catheterization led to quicker time to PUR resolution and was associated with a higher satisfaction rate than continuous catheterization, with no additional complications, a study from Israel reports.

CHAP backs BP control during pregnancy, even for mild hypertension

Tighter BP control improves pregnancy outcomes in women with DM, chronic hypertension

Jairia Dela Cruz, 20230223200000

Further lowering blood pressure helps cut the risk of adverse perinatal events for pregnant women with pregestational diabetes mellitus (DM) and mild chronic hypertension, according to the secondary analysis of the Chronic Hypertension and Adverse Pregnancy (CHAP) study presented at SMFM 2023.

Increased ketorolac doses reduce opioid use following caesarean delivery

Audrey Abella, 20230223100000

In women undergoing caesarean section (C-section), six scheduled doses of ketorolac reduced postoperative opioid use as opposed to having only two doses.

Labetalol, nifedipine equally effective for chronic hypertension in pregnancy

Elaine Soliven, 20230223000000

Treatment with either labetalol or nifedipine is similarly effective in reducing adverse maternal outcomes among women with mild chronic hypertension (CHTN) in pregnancy, according to a study presented at SMFM 2023.

Cannabis use among expectant mums compromises pregnancy

Jairia Dela Cruz, 20230222150000

Pregnant women may do well to avoid cannabis, with cannabis use in early pregnancy leading to adverse pregnancy outcomes, as reported in a study presented at Society for Maternal-Fetal Medicine (SMFM) 43rd Annual Pregnancy Meeting.

Which ART delivers better HIV viral suppression in pregnant women?

Stephen Padilla, 20230222120000

Pregnant women living with HIV are more likely to achieve viral suppression when treated with dual-nucleoside reverse transcriptase inhibitors (NRTI) in combination with integrase (INSTI) inhibitors compared to protease (PI) inhibitors at delivery, suggests a recent study presented at the 43rd Annual Pregnancy Meeting of the Society for Maternal Fetal Medicine (SMFM 2023).

Can oxytocin be discontinued during active labour?

Elvira Manzano, 20230222000000

Discontinuing oxytocin during the active stage of labour appears safe, according to the STOPOXY trial presented at SMFM 2023.

Hypertensive disorders of pregnancy tied to fatty, salty diet

Stephen Padilla, 20230221120000

Women who adhere to a diet rich in sodium, dairy, and saturated fats are at increased risk of hypertensive disorders of pregnancy (HDP), according to a study presented at the 43rd Annual Pregnancy Meeting of the Society for Maternal Fetal Medicine (SMFM 2023).

Vacuum-induced device controls postpartum haemorrhage in just 5 mins

Elvira Manzano, 20230217000000

Uncontrolled postpartum haemorrhage (PPH) is a life-threatening complication of childbirth that is temporarily managed with uterine balloon tamponade. At SMFM 2023, researchers from the US presented findings for a new device that could control PPH safely and effectively in just 5 minutes.

Single-dose azithromycin during labour prevents maternal death, sepsis

Elaine Soliven, 20230215000000

Treatment with a single oral dose of azithromycin, given to women in labour who were planning a vaginal birth, significantly reduced the risk of maternal death or sepsis, according to the A-PLUS* trial presented at SMFM 2023.